[Treatment of small renal masses: Effectiveness and cost-comparison analysis].
CONCLUSION: According to current repayment terms, the LPN was the treatment of SRM that offered the best profitability.
LEVEL OF EVIDENCE: 4.
PMID: 26718411 [PubMed - as supplied by publisher]
Source: Progres en Urologie - Category: Urology & Nephrology Tags: Prog Urol Source Type: research
More News: Cancer | Cancer & Oncology | Cryotherapy | Health | Health Insurance | Insurance | Kidney Cancer | Laparoscopy | Nephrectomy | Study | Urology & Nephrology